Krakow, Poland – 03 October – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology patients and drug discovery services, will participate and present during the “Leukemia and Lymphoma – Europe and the USA Linking Knowledge and Practice”, which is taking place 3 –…
Selvita presents at the 18th Annual Biotech in Europe Forum
Krakow, Poland – 02 October – Selvita will participate and present at the upcoming 18th Annual Biotech in Europe Forum, which will take place 4 – 5 October 2018 in Basel, Switzerland. The conference is organized by Sachs Associates. Selvita is scheduled to present a corporate overview at 14:15 on Thursday,…
Selvita participates as a panelist at the Charting Poland’s Future Event: Spotlight on Growth & Innovation
Krakow, Poland – 24 September – Selvita will participate as a panelist at the “Charting Poland’s Future Event: Spotlight on Growth & Innovation”, which is taking place on September 25, 2018, in London, in Bloomberg’s new European Headquarters. Selvita CEO Pawel Przewiezlikowski will participate in a panel discussion “The View…
Selvita presents and exhibits at the upcoming Medicinal Chemistry Summit: USA
Krakow, Poland – 13 September 2018 – Selvita will present and exhibit at the upcoming Medicinal Chemistry Summit: USA, which will be held on 17–18 September 2018 at the Hyatt Regency, Boston Harbour (MA, USA). The Summit is designed for those working across all areas of medicinal chemistry. The international…
Selvita demonstrates dynamic and strong revenue growth in H1 2018
Krakow, Poland – 11 September 2018 – Selvita, one of the largest drug discovery companies in Europe, has recently published semiannual financial results demonstrating its strong and dynamic business growth. In H1 2018 Service Segment recognized a significant increase in revenues and greater operating profitability, comparing to H1 2017. Revenues…
Selvita presents at the 25th Annual BioCentury NewsMakers in the Biotech Industry
Krakow, Poland – 03 September 2018 – Selvita will participate and present at the upcoming 25th Annual BioCentury NewsMakers in the Biotech Industry Conference, which is taking place on September 7, 2018, in New York, USA. Pawel Przewiezlikowski, the CEO of Selvita, is scheduled to present a corporate overview at…